Referencias►
1.
Lee RE.
Phycology.
2nd ed. Cambridge: Cambridge University Press; 1989: 91.
2.
Dillon JC, Phuc AP, Dubacq JP
.
Nutritional value of the alga spirulina.
World Rev Nutr Diet. 1995;77:32 - 46.
3.
Dagnelie P, van Staveren WA, van den Berg H
.
Vitamin B-12 from algae appears not to be bioavailable.
Am J Clin Nutr. 1991;53:695 - 697.
4.
Facts and Comparisons. Spirulina Monograph.
The Review of Natural Products.February 1998.
5.
Becker EW, Jakober B, Luft D, et al
.
Clinical and biochemical evaluations of the alga
Spirulina
with regard to its application in the treatment of obesity. A double-blind cross-over study.
Nutr Rep Int. 1986;33:565 - 574.
6.
Merchant RE, Andre CA. A review of recent clinical trials of the nutritional supplement
Chlorella pyrenoidosa
in the treatment of fibromyalgia, hypertension, and ulcerative colitis.
Altern Ther Health Med. 2001;7:79 - 80, 82 - 91.
7.
Iwata K, Inayama T, Kato T
.
Effects of
Spirulina platensis
on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats.
J Nutr Sci Vitaminol.
1990;36:165 - 171.
8.
Gonzalez de Rivera C, Miranda-Zamora R, Diaz-Zagoya JC, et al
.
Preventive effect of
Spirulina maxima
on the fatty liver induced by a fructose-rich diet in the rat, a preliminary report.
Life Sci. 1993;53:57 - 61.
9.
Nakaya N, Homma Y, Goto Y
.
Cholesterol lowering effect of spirulina.
Nutr Rep Int. 1988;37:1329 - 1337.
10.
Schwartz J, Shklar G, Reid S, et al. Prevention of experimental oral cancer by extracts of
Spirulina-Dunaliell
a algae.
Nutr Cancer. 1988;11:127 - 134.
11.
Mathew B, Sankaranarayanan R, Nair PP, et al. Evaluation of chemoprevention of oral cancer with
Spirulina fusiformis. Nutr Cancer. 1995;24:197 - 202.
12.
Mishima T, Murata J, Toyoshima M, et al
.
Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga,
Spirulina platensis.Clin Exp Metastasis. 1998;16:541 - 550.
13.
Ayehunie S, Belay A, Baba TW, et al
.
Inhibition of HIV-1 replication by an aqueous extract of
Spirulina platensis (Arthrospira platensis).J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:7 - 12.
14.
Hayashi K, Hayashi T, Kojima I
.
A natural sulfated polysaccharide, calcium spirulan, isolated from
Spirulina platensis:
in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities.
AIDS Res Hum Retroviruses. 1996;12:1463 - 1471.
15.
Qureshi MA, Ali RA.
Spirulina platensis
exposure enhances macrophage phagocytic function in cats.
Immunopharmacol Immunotoxicol. 1996;18:457 - 463.
16.
Qureshi MA, Garlich JD, Kidd MT
.
Dietary
Spirulina platensis
enhances humoral and cell-mediated immune functions in chickens.
Immunopharmacol Immunotoxicol. 1996;18:465 - 476.
17.
Hayashi O, Katoh T, Okuwaki Y
.
Enhancement of antibody production in mice by dietary
Spirulina platensis. J Nutr Sci Vitaminol.
1994;40:431 - 441.
18.
Kim HM, Lee EH, Cho HH, et al. Inhibitory effect of mast cell-mediated immediate-type allergic reactions in rats by spirulina.
Biochem Pharmacol. 1998;55:1071 - 1076.
19.
Yang HN, Lee EH, Kim HM.
Spirulina platensis
inhibits anaphylactic reaction.
Life Sci. 1997;61:1237-1244.
20.
Torres-Duran PV, Miranda-Zamora R, Paredes-Carbajal MC, et al
. Spirulina maxima
prevents induction of fatty liver by carbon tetrachloride in the rat.
Biochem Mol Biol Int. 1998;44:787 - 793.
21.
Vadiraja BB, Gaikwad NW, Madyastha KM
.
Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and
R
-(+)-pulegone-mediated hepatotoxicity in rats.
Biochem Biophys Res Commun. 1998;249:428 - 431.
22.
Merchant RE, Andre CA. A review of recent clinical trials of the nutritional supplement
Chlorella pyrenoidosa
in the treatment of fibromyalgia, hypertension, and ulcerative colitis.
Altern Ther Health Med. 2001;7:79 - 80, 82 - 91.
23.
Merchant RE, Andre CA. A review of recent clinical trials of the nutritional supplement
Chlorella pyrenoidosa
in the treatment of fibromyalgia, hypertension, and ulcerative colitis.
Altern Ther Health Med. 2001;7:79 - 80, 82 - 91.
24.
Becker EW, Jakober B, Luft D, et al. Clinical and biochemical evaluations of the alga Spirulina with regard to its application in the treatment of obesity. A double-blind cross-over study.
Nutr Rep Int. 1986;33:565 - 574.
25.
Dillon JC, Phuc AP, Dubacq JP
.
Nutritional value of the alga spirulina.
World Rev Nutr Diet. 1995;77:32 - 46.
26.
Salazar M, Chamorro GA, Salazar S, et al
.
Effect of
Spirulina maxima
consumption of reproduction and peri- and postnatal development in rats.
Food Chem Toxicol.1996;34:353 - 359.
27.
Chamorro GA, Herrera G, Salazar M, et al. Short-term toxicity study of Spirulina in F3b generation rats.
J Toxicol Clin Exp.
1988;8:163 - 167.
28.
Facts and Comparisons. Spirulina Monograph.
The Review of Natural Products.February 1998.
29.
Facts and Comparisons. Spirulina Monograph.
The Review of Natural Products.February 1998.
30.
Pouria S, de Andrade A, Barbosa J, et al. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil.
Lancet. 1998;352:21 - 26.
31.
Gilroy DJ, Kauffman KW, Hall RA, et al. Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements.
Environ Health Perspect. 2000;108:435 - 439.
32.
Islam MS, Rahim Z, Alam MJ, et al. Association of Vibrio cholerae O1 with the cyanobacterium, Anabaena sp., elucidated by polymerase chain reaction and transmission electron microscopy.
Trans R Soc Trop Med Hyg. 1999;93:36 - 40.
33.
Johnson PE, Shubert LE. Accumulation of mercury and other elements by
Spirulina (Cyanophyceae). Nutr Rep Int. 1986;34:1063 - 1070.
34.
Slotton DG, Goldman CR, Franke A. Commercially grown spirulina found to contain low levels of mercury and lead.
Nutr Rep Int. 1989;40:1165 - 1171.
35.
Jochimsen EM, Carmichael WW, An JS, et al. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil.
N Engl J Med. 2003;338:873 - 878.
36.
Astrachan NB, Archer BG, Hilbelink DR. Evaluation of the subacute toxicity and teratogenicity of anatoxin-a.
Toxicon. 1980;18:684 - 688.
